tradingkey.logo

BUZZ-Emergent BioSolutions falls after reporting downbeat quarterly revenue

ReutersMar 3, 2025 10:10 PM

Shares of Emergent BioSolutions EBS.N fall 12.5% to $5.98 in extended trading, the lowest since September

Company reported a decline in its fourth-quarter revenue, which stood at $194.7 million, down from $276.6 million a year ago

On an adjusted basis, company reported EPS of 5 cents, vs a loss of 77 cents previous year

Company is moving forward with turnaround activities, a critical phase in its multi-year transformation plan - EBS

Company's shares up 298.3% in 2024

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI